3rd Annual Gene Therapy Immunogenicity Summit

The 3rd Annual Gene Therapy Immunogenicity Summit is organized by Hanson Wade and will be held from Oct 18 - 20, 2022 at The Colonnade Hotel, in Boston, Massachusetts, United States of America.

Description:
The 3^rd Annual Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure, and predict the immune response of your gene therapy candidate. This summit will bring together large pharma and innovative biotechs to ensure that you are up to speed on the latest approaches to evaluate and overcome pre-existing immunity to AAV vectors, understand how immune-modulatory strategies can help to ensure efficacy and safety, and learn the reality of regulatory expectations around immunological assays. This is important because there is uncertainty surrounding the challenges posed by immune responses to delivery and the increasing clinical activity in gene therapy. This is your chance to learn in-depth technical information about the differences between immunogenicity experienced across organs and administration routes, how models can be improved to enable comparative immunology between species, and what the most recent clinical data tell us about how to adapt current clinical mitigation strategies to address immunogenicity. This book incorporates the insights of top immunological, bioanalytical, and translational experts. 
Don't miss your chance to join over 100 other industry experts to network in person and share your research as you look for new and improved methods of predicting immunogenicity in the clinic to ultimately ensure the safety and efficacy of gene therapies. There will be 35+ industry-based speakers covering pre-clinical and clinical immunogenicity challenges over 2 tracks and 3 jam-packed days of content. 

Additional Details Will Be Posted as Soon as Information Is Available.